ResMed said it would release a new generation of air flow generators - the ResMed S9 series - in Europe and the Americas in the third quarter. Mr Gallahue said the S9 series had "the potential to establish a new level within the market place". Mr Gallahue said ResMed was continuing to drive market expansion. "We are taking steps to increase awareness of the health dangers of sleep-disordered breathing by sponsoring educational programs targeted at the primary-care physician community," he said. Shares in ResMed were 35 cents, or 5.84 per cent, higher at $6.34 on Friday on the Australian stock exchange.